0001493152-23-000319.txt : 20230104
0001493152-23-000319.hdr.sgml : 20230104
20230104161042
ACCESSION NUMBER: 0001493152-23-000319
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20221229
FILED AS OF DATE: 20230104
DATE AS OF CHANGE: 20230104
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Adkins William
CENTRAL INDEX KEY: 0001945434
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-41488
FILM NUMBER: 23506441
MAIL ADDRESS:
STREET 1: SHUTTLE PHARMACEUTICALS HOLDINGS, INC.
STREET 2: ONE RESEARCH COURT, SUITE 450
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Shuttle Pharmaceuticals Holdings, Inc.
CENTRAL INDEX KEY: 0001757499
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: ONE RESEARCH COURT
STREET 2: SUITE 450
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
BUSINESS PHONE: 2404034212
MAIL ADDRESS:
STREET 1: ONE RESEARCH COURT
STREET 2: SUITE 450
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
4
1
ownership.xml
X0306
4
2022-12-29
1
0001757499
Shuttle Pharmaceuticals Holdings, Inc.
SHPH
0001945434
Adkins William
C/O SHUTTLE PHARMACEUTICALS HOLDINGS
ONE RESEARCH COURT, SUITE 450
ROCKVILLE
MD
20850
0
0
0
1
Former Director
COMMON STOCK
2022-12-29
4
S
0
995
1.605
D
184071
D
WARRANTS (right to buy)
4.00
2022-09-02
4
J
0
138889
A
2022-09-02
2025-09-02
Common Stock
138889
138889
D
Represents the number of shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of 2,702 restricted stock units ("RSUs") held by the Reporting Person. Upon vesting of the RSUs, the sales are automatic, routine, non-discretionary transactions mandated by the Issuer under its equity incentive plan in order to satisfy the Reporting Person's tax withholding obligations which are funded by "sell to cover" transactions. These transactions are exempt under Section 16b-3 and do not represent discretionary trades by the Reporting Person.
Consists of (i) 1,707 shares of Common Stock held by the Reporting Person and (ii) 182,364 shares of common stock held by the William Henry Adkins and Pauline Adkins 1993 Revocable Trust (the "Adkins Trust").
Consists of warrants to purchase 138,889 shares of common stock held by the Adkins Trust. The Adkins Trust was a holder of the Issuer's Series A convertible preferred stock, which stock converted into commons stock upon completion of the Issuer's IPO and at which time the warrants were issued to the Series A holders in accordance with the terms of the Series A preferred stock offering.
Previously, the Reporting Person's warrant holdings had been reported in Table I of the Reporting Person's Form 3. This Form 4 has corrected the error and moved the warrant holdings to Table II. The Reporting Person ceased being a director of SHPH in December 2022 and is no longer subject to Section 16 reporting requirements.
/s/ William H. Adkins
2023-01-04